Usefulness of erythropoietin and G-CSF during treatment for chronic hepatitis C with pegylated interferon: A clinical descriptive analysis.

被引：0
|
作者：
Lebray, P [1 ]
Pichard, AV [1 ]
Broissand, C [1 ]
Nalpas, B [1 ]
Sobesky, R [1 ]
Fontaine, H [1 ]
Pol, S [1 ]
机构：
[1] AP HP, Paris, France
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1644
引用
收藏
页码：574A / 574A
页数：1
相关论文
共 50 条
  • [31] Treatment of chronic hepatitis C in children with pegylated interferon and ribavirin : the impact of dose
    Tufano, Maria
    Cicalese, Maria Pia
    Spagnuolo, Maria Immacolata
    Terlizzi, Vito
    Iorio, Raffaele
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2015, 78 (01): : 8 - 11
  • [32] Chronic hepatitis C virus infection in dialysis patients and treatment with pegylated interferon
    Sikole, A
    Dzekova, P
    Asani, A
    Selim, GJ
    Amitov, V
    Gelev, S
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2006, 29 (05): : 502 - 502
  • [33] Treatment Outcomes With Pegylated Interferon and Ribavirin for Male Prisoners With Chronic Hepatitis C
    Chew, Kara W.
    Allen, Scott A.
    Taylor, Lynn E.
    Rich, Josiah D.
    Feller, Edward
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2009, 43 (07) : 686 - 691
  • [34] Pegylated Interferon Monotherapy of Chronic Hepatitis C in Dialysis Patients: Meta-Analysis of Clinical Trials
    Fabrizi, Fabrizio
    Dixit, Vivek
    Messa, Piergiorgio
    Martin, Paul
    JOURNAL OF MEDICAL VIROLOGY, 2010, 82 (05) : 768 - 775
  • [35] Serum erythropoietin concentration increases during α-interferon and ribavirin combination treatment for chronic hepatitis C.
    Mangoni, ED
    Saviano, D
    Utili, R
    Adinolfi, LE
    Giordano, M
    Ruggiero, G
    HEPATOLOGY, 2001, 34 (04) : 417A - 417A
  • [36] Suboptimal endogenous erythropoietin response in chronic hepatitis C patients during ribavirin and PEG interferon treatment
    Van Vlerken, Lotte G.
    Van Soest, Hanneke
    Janssen, Mart P.
    Boland, Greet J.
    Drenth, Joost P. H.
    Burger, David M.
    Siersema, Peter D.
    Van Erpecum, Karel J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (11) : 1308 - 1315
  • [37] Pegylated-interferon and ribavirin for recurrent hepatitis C after liver transplantation - A preliminary analysis.
    Mukherjee, S
    Gilroy, RK
    McCashland, TM
    Schafer, DF
    Zetterman, RK
    Sorrell, MF
    HEPATOLOGY, 2002, 36 (04) : 184A - 184A
  • [38] Pegylated interferon, ribavirin and amantadine for treatment of chronic hepatitis C: A multi-center clinical trial.
    Younossi, ZM
    McCullough, AJ
    Barnes, DS
    Post, A
    Ong, JP
    Mullen, KD
    Carey, WD
    O'Shea, R
    Levinthal, G
    Gramlich, T
    Martin, L
    Bringman, D
    Tavill, AS
    Ferguson, DR
    HEPATOLOGY, 2002, 36 (04) : 603A - 603A
  • [39] Preclinical and Clinical Development of Pegylated Interferon-Lambda 1 in Chronic Hepatitis C
    Ramos, Eleanor L.
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2010, 30 (08): : 591 - 595
  • [40] Impact of early elevation of serum bilirubin during treatment with pegylated interferon and ribavirin in patients with chronic hepatitis C
    Ishigami, Masatoshi
    Hayashi, Kazuhiko
    Katano, Yoshiaki
    Itoh, Akihiro
    Hirooka, Yoshiki
    Goto, Hidemi
    HEPATOLOGY RESEARCH, 2010, 40 (10) : 963 - 970
12345